Healthequity (HQY) Revenue (2013 - 2026)

Healthequity's Revenue history runs 14 years deep, the most recent figure standing at $354.6 million for Q2 2026.

• On a quarterly basis, Revenue rose 7.19% year-over-year to $354.6 million in Q2 2026; TTM through Apr 2026 was $1.3 billion, a 7.58% increase from a year earlier, with the FY2026 full-year figure at $1.3 billion, up 9.47% from the prior year.
• Revenue improved to $354.6 million in Q2 2026 per HQY's latest filing, from $334.6 million in the prior quarter.
• Across five years, Revenue topped out at $354.6 million in Q2 2026 and bottomed at $203.3 million in Q1 2022.
• The 5-year median for Revenue is $275.0 million (2024), against an average of $274.0 million.
• Across the five-year window, Revenue climbed 23.15% in 2024 and increased 7.19% in 2026, its largest moves.
• Year by year, Revenue stood at $216.1 million in 2022, then grew by 15.33% to $249.2 million in 2023, then increased by 20.55% to $300.4 million in 2024, then rose by 7.23% to $322.2 million in 2025, then rose by 10.08% to $354.6 million in 2026.
• Per Business Quant, the three latest HQY Revenue figures stand at $354.6 million (Q2 2026), $334.6 million (Q1 2026), and $322.2 million (Q4 2025).